Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
McCammon covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Celcuity, and Corbus Pharmaceuticals. According to TipRanks, McCammon has an average return of 88.0% and a 64.91% success rate on recommended stocks.
In addition to LifeSci Capital, Perspective Therapeutics also received a Buy from JonesTrading’s Justin Walsh in a report issued on May 14. However, on May 12, Bank of America Securities reiterated a Hold rating on Perspective Therapeutics (NYSE MKT: CATX).
Based on Perspective Therapeutics’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $76 thousand and a GAAP net loss of $26.19 million. In comparison, last year the company had a GAAP net loss of $18.18 million
